Drawing for MELTDOSE

USPTO serial 78219715

MELTDOSE

Reviewed by CopyMark Law Group

Reg. 2959361Status 710
Filing date
Status date
Registration date
Jun 7, 2005
Examiner
CLARK, GLENN
Law office
TMO LAW OFFICE 115

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with MELTDOSE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Julia Anne Matheson

Julia Anne Matheson Potomac Law Group, PLLC1300 Pennsylvania Avenue, NWSuite 700Washington, DC 20004

Goods and services

ClassDescriptionStatusFirst use
005[ Pharmaceutical preparations; medical preparations; and drug delivery systems, ] pharmaceutical modified release systems, and controlled release systems, comprised of tablets, [ granules, pills, sachets, powders, and capsules; ] all of the above for use in the treatment of [ mental and physical disorders, traumas and emergencies, addictions, aging, allergy/immunology, burns, ] diseases of [ the heart and ] blood vessels, [ dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, ] diseases of the blood, [ infectious diseases, neurological diseases, nephrological diseases, diseases in the obstetrical- and gynecological field, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and throat, diseases and afflictions in the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions and generalised pain ]SECTION 8 - CANCELLED—
041[ Educational training services, namely, arranging and conducting of seminars, workshops, conferences, lectures and congresses, all in the medical, chemical, and pharmaceutical fields ]SECTION 8 - CANCELLED—
042[ Scientific research, namely, bacteriological research, biological research, biotechnological research, scientific research services for medical purposes and scientific research consultation; research and development for new products for others; industrial design services; pharmaceutical and medical consultation regarding pharmaceutical drug development services; cosmetic research for others; design services for others in the field of medical packaging and equipment; medical research; medical and scientific research, namely, conducting clinical trials, namely, testing of medical substances and testing of medical applications; pharmaceutical drug development services, namely, development of medical applications, drug design, drug formulation, pharmaceutical formulation, and development of pharmaceutical formulations and consultation regarding pharmaceutical formulation; ] development of drug delivery systems for others, namely, development of solid dosage forms, pharmaceutical controlled release systems, modified release systems and pharmaceutical modified release systems and consultation related thereto; [ pharmaceutical drug development services, namely, development of mixing technology, development of particulate material, development of particulate material mixing technology, development of granulate technology, development of tabletting technology, and consultation related thereto ]SECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 19, 2025CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Jun 7, 2024REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Mar 21, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 21, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 21, 2023EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Mar 21, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 21, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 21, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 8, 2021ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Nov 28, 2017CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 28, 2017COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 10, 2015NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Jun 10, 2015RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Jun 10, 20159G8PREGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8—
Jun 10, 20158PRTREGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED—
Jun 4, 2015E89RTEAS SECTION 8 & 9 RECEIVED—
Dec 19, 2011NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - MAILED—
Dec 19, 20118.PRREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED—
Dec 16, 2011APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Dec 7, 20118.AFREGISTERED - SEC. 8 (6-YR) FILED—
Dec 7, 2011ES8RTEAS SECTION 8 RECEIVED—
Nov 23, 2011ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jun 7, 2005R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 15, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 23, 2005NPUBNOTICE OF PUBLICATION—
Dec 29, 2004PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 29, 2004MAILPAPER RECEIVED—
Aug 30, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 27, 2004ALIEASSIGNED TO LIE—
Aug 25, 2004ALIEASSIGNED TO LIE—
Aug 24, 2004XAECEXAMINER'S AMENDMENT ENTERED—
Aug 24, 2004GNEAEXAMINERS AMENDMENT E-MAILED—
May 19, 2004CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 10, 2004ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
May 3, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 19, 20041.BDSec. 1(B) CLAIM DELETED—
Feb 19, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 19, 2004MAILPAPER RECEIVED—
Feb 17, 2004TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 25, 2003GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 20, 2003DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance